Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Stavudine
Drug ID BADD_D02068
Description A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Indications and Usage For the treatment of human immunovirus (HIV) infections.
Marketing Status Prescription; Discontinued
ATC Code J05AF04
DrugBank ID DB00649
KEGG ID D00445
MeSH ID D018119
PubChem ID 18283
TTD Drug ID D0Z8EX
NDC Product Code 65862-047; 68554-0045; 65862-046; 65862-111; 65015-672; 65862-112; 68554-0015; 65015-795; 53104-0111; 65862-263; 65862-342
Synonyms Stavudine | D4T | 2',3'-Didehydro-3'-deoxythymidine | 2',3' Didehydro 3' deoxythymidine | 2',3'-Didehydro-2',3'-dideoxythmidine | Zerit | BMY-27857 | BMY 27857 | BMY27857 | Stavudine, Monosodium Salt
Chemical Information
Molecular Formula C10H12N2O4
CAS Registry Number 3056-17-5
SMILES CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rhinitis22.07.03.006; 11.01.13.004--
Sensory loss17.02.07.007--Not Available
Sinusitis11.01.13.005; 22.07.03.007--
Skin disorder23.03.03.007--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Stillbirth18.01.02.002; 08.04.01.006--Not Available
Stomatitis07.05.06.005--
Thinking abnormal17.02.05.023; 19.10.03.001--Not Available
Thrombocytopenia01.08.01.002--Not Available
Urinary tract infection20.08.02.001; 11.01.14.004--
Urticaria23.04.02.001; 10.01.06.001--
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Fat redistribution14.08.04.002--Not Available
Lipodystrophy acquired23.07.01.003; 14.08.04.0080.008680%Not Available
Lymphatic disorder01.09.01.003--Not Available
Foetor hepaticus09.01.05.006; 07.01.06.026--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Mitochondrial toxicity12.03.01.009; 14.11.02.0010.010126%Not Available
Affect lability19.04.01.001--Not Available
Body fat disorder14.08.04.012--Not Available
Metabolic disorder14.11.01.001--Not Available
Neurological symptom17.02.05.010--Not Available
Connective tissue disorder15.06.01.006--Not Available
Inflammation08.01.05.007--Not Available
Malnutrition14.03.02.004--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Blood disorder01.05.01.004--Not Available
Autoimmune disorder10.04.04.003--
The 4th Page    First    Pre   4 5    Next   Last    Total 5 Pages